Latest filing published 14 Oct 2026 for GSK plc, €14k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Philip Thomson is a declared insider of GSK plc, with filings sourced from RNS (LSE). Over a trading history stretching from 8 February 2024 to 12 October 2026, the count stands at 71 filings.
Purchases make up the whole of the open-market record (1 purchase). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 70 share grants. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 14 October 2026, reports a share grant of €14k in GSK plc. The last insider purchase was made public on 13 January 2026, 277 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 3 days. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 66 declarations
GSK executives bought 14 shares each at £18.0296 on September 9. Read the cluster against pharma peers, Q2 guidance, and...
GSK’s 10-person buy cluster is tiny in cash terms, but it arrives as pharma trades through trial risk, rate pressure and...